Pioglitazone improves the ability of learning and memory via activating ERK1/2 signaling pathway in the hippocampus of T2DM rats

被引:14
|
作者
Gao, F. [1 ,2 ]
Zang, L. [1 ]
Wu, D. Y. [2 ]
Li, Y. J. [1 ]
Zhang, Q. [1 ]
Wang, H. B. [1 ]
Tian, G. L. [1 ]
Mu, Y. M. [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing 100853, Peoples R China
[2] First Hosp Shijiazhuang City, Dept Endocrinol, Shijiazhuang 050011, Peoples R China
关键词
Pioglitazone; Extracellular signal regulated kinase; Raf-1 kinase inhibitory protein; Type 2 diabetes mellitus; Learning and memory; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; COGNITIVE IMPAIRMENT; BRAIN; RECEPTOR; PROTEIN; KINASE; ADULTS; GAMMA; MECHANISM;
D O I
10.1016/j.neulet.2017.04.052
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
OBJECTIVE: To explore the correlation between effect of PIO (pioglitazone, PIO) on learning as well as memory and ERK1/2 (extracellular signal regulated kinase 1/2, ERK1/2) pathway in T2DM (type 2 diabetes mellitus, T2DM) rats, further to elucidate the potential mechanism of PIO in improvement of learning and memory. METHODS: 12-week-old male SD rats (number of 10 per group) were randomly divided into control group (CON), T2DM group (DM) and T2DM +PIO group (DM + PG). Rats in DM and DM + PG groups were given high fat diet for 20 weeks, then treated with Streptozotocin (27 mg/kg) by intraperitoneal injection at 2lweek. After 72 h, the FBG (fasting blood glucose, FBG) was greater than 7.0 mmol/L can considered T2DM rats. DM + PG group was treated with PIO (10 mg.kg(-1).d(-1)) by gavage daily. After Hyperinsulinemic-Euglycemic Clamp Study and Morris water maze test at 30-week, all of animals were sacrificed. The expressions of RKIP (Raf-1 kinase inhibitor protein, RKIP) and ERK1/2 in hippocampus were detected using Western Blot and real-time PCR. RESULTS: The FBG level: DM group (7.68 +/- 0.54 mmol/L) was higher than CON group (5.35 +/- 0.63 mmol/L) and DM + PG group (6.07 +/- 0.84 mmol/L), the differences were considered statistically significant (P < 0.05). Hyperinsulinemic-Euglycemic Clamp Studies: GIR (glucose infusion rate, GIR) of DM group (21.02 +/- 5.10 mg.kg(-1).d(-1)) was less than CON group (27.64 +/- 3.87 mg.kg(-1).d(-1)) and DM +PG group (26.04 +/- 5.41 mg.kg(-1)d(-1)), the differences were considered statistically significant (P <0.05). Morris water maze training: The escape latencies and searching platform performance of DM group (24.54 +/- 5.02s) decreased significantly compared with CON group (16.73 +/- 4.02s) and DM + PG group (18.05 +/- 4.12s) (P <0.05). Changes of RKIP, ERK, p-ERK protein relative content in rat hippocampus: Compared with CON groupand DM+ PG group, the relative content of RKIP in DM group remarkably increased (P < 0.01); ERK protein levels were not considered statistically significant among the three groups (P >0.05); The relative content of p-ERK1/2 protein in CON group and DM + PG group rats dorsal were higher than those in group DM, the difference was considered statistically significant (P < 0.01). Changes in hippocampus of rat RKIP and ERR gene relative content: Compared with CON group and DM+ PG group, levels of RKIP mRNA in DM group were significantly increased (P < 0.01); ERR mRNA levels were not considered statistically significant among the three groups (P>0.05). CONCLUSION: Activation of ERK1/2 signal transduction pathway via reducing RKIP in the hippocampus may be one of the mechanisms of PIO to improve the learning and memory of the T2DM rats. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:165 / 170
页数:6
相关论文
共 50 条
  • [31] Urocortin stimulates the ERK1/2 signaling pathway and the proliferation of HeLa cells via CRF receptor 1
    Balogh, Balint
    Vecsernyes, Monika
    Stayer-Harci, Alexandra
    Berta, Gergely
    Tarjanyi, Oktavia
    Setalo, Gyorgy, Jr.
    FEBS OPEN BIO, 2023, 13 (05): : 818 - 832
  • [32] Addition of pioglitazone and ramipril to intensive insulin therapy in T2DM improves vascular dysfunction by different mechanisms
    Fernandez, Marianella
    Trplitt, Curtis
    Cervera, Antonio
    Wajcberg, Estela
    Cusi, Ken
    Defronzo, Ralph A.
    Cersosimo, Eugenio
    DIABETES, 2007, 56 : A69 - A69
  • [33] Electroacupuncture alleviates cerebral ischemia and reperfusion injury via modulation of the ERK1/2 signaling pathway
    Xiao-lu Jin
    Peng-fei Li
    Chun-bing Zhang
    Jin-ping Wu
    Xi-lian Feng
    Ying Zhang
    Mei-hong Shen
    NeuralRegenerationResearch, 2016, 11 (07) : 1090 - 1098
  • [34] CURCUMIN TRINICOTINATE REGULATE THE PROLIFERATION OF VSMCS VIA CAVEOLIN-1/ERK1/2 SIGNALING PATHWAY
    Yang, W.
    Li, T. P.
    Tuo, Q. H.
    Zheng, X.
    Guo, Z. F.
    Liao, D. F.
    CARDIOLOGY, 2013, 125 : 465 - 465
  • [35] Pioglitazone (PIO) improves glycemic control in drug-therapy naive patients with type 2 diabetes (T2DM)
    Herz, M
    Tan, M
    Johns, D
    Robertson, KE
    Gonzalez, B
    Reviriego, J
    Grossman, L
    DIABETES, 2002, 51 : A481 - A481
  • [36] Empagliflozin as Add-On to Pioglitazone With or Without Metformin Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)
    Kovacs, Christopher
    Seshiah, Veeraswamy
    Swallow, Ros
    Jones, Russell
    Rattunde, Henning
    Woerle, Hans J.
    Broedl, Uli C.
    DIABETES, 2013, 62 : A291 - A291
  • [37] Pioglitazone (PIO) improves atherogenic dyslipidemia in drug-therapy naive patients with type 2 diabetes (T2DM)
    Tan, MH
    Herz, M
    Johns, D
    Robertson, KE
    Gonzalez, B
    Reviriego, J
    Grossman, LD
    DIABETES, 2002, 51 : A497 - A497
  • [38] Neuroprotective effects of DAAO are mediated via the ERK1/2 signaling pathway in a glaucomatous animal model
    Zhang, Xuejin
    Zhang, Rong
    Chen, Junyi
    Wu, Jihong
    EXPERIMENTAL EYE RESEARCH, 2020, 190
  • [39] Cyanidin-3-glucoside Regulates Osteoblast Differentiation via the ERK1/2 Signaling Pathway
    Hu, Bosen
    Chen, Lin
    Chen, Yong
    Zhang, Zhuo
    Wang, Xiaohong
    Zhou, Bo
    ACS OMEGA, 2021, 6 (07): : 4759 - 4766
  • [40] Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma
    Qu, Huiling
    Song, Xiaofu
    Song, Zhuyin
    Jiang, Xin
    Gao, Xin
    Bai, Lijuan
    Wu, Jiao
    Na, Li
    Yao, Zhicheng
    CANCER CELL INTERNATIONAL, 2020, 20 (01)